| Antibiotics |
1 |
1 |
| Genomic Medicine |
0 |
0.9 |
| CRISPR |
0 |
0.53 |
| Antibiotic Resistance |
0 |
0.99 |
| Bacteria |
0 |
0.41 |
| Precision Medicine |
0 |
0.98 |
| Biologic Therapy |
0 |
0.29 |
| Pharmacogenomics |
0 |
0.27 |
| Microbiome |
0 |
0.24 |
| Diversity |
0 |
0.2 |
| Microbicides |
0 |
0.2 |
| Microbiology |
0 |
0.2 |
| Antimicrobial Resistance |
0 |
0.19 |
| Healthcare and Medical Technology |
0 |
0.16 |
| Artificial Intelligence |
0 |
0.14 |
| Spain |
0 |
0.14 |
| Gene Editing |
0 |
0.12 |
| Social Determinants of Health |
0 |
0.12 |
| Electronic Medical Record |
0 |
0.1 |
| Adverse Effects |
0 |
0.07 |
| Allergy |
0 |
0.07 |
| Bioinformatics |
0 |
0.07 |
| Clinical Research |
0 |
0.07 |
| Genetics |
0 |
0.07 |
| Medical Records |
0 |
0.07 |
| Pharmacodynamics |
0 |
0.07 |
| Pharmacokinetics |
0 |
0.07 |
| Pseudomonas Aeruginosa Infection |
0 |
0.07 |
| Staphylococcus Aureus Infection |
0 |
0.07 |
| Therapeutic Drug Monitoring |
0 |
0.07 |
| Tuberculosis |
0 |
0.07 |
| Electronic Health Record (EHR) |
0 |
0.04 |
| Obesity |
0 |
0.04 |
| Patient Safety |
0 |
0.04 |
| Staphylococcal Infection |
0 |
0.04 |
| Toxicology |
0 |
0.04 |